The Invisible Cancer - Bringing Visibility to Neuroendocrine CancerÂ
The Invisible Cancer Podcast raises awareness of neuroendocrine cancer, a cancer most people have never heard of, and this lack of awareness can affect diagnosis, treatment, and care. Through real-life stories, expert insights, and practical advice, we explore the challenges patients face, from initial diagnosis to management, including the impact on mental health and ongoing follow-up.
Hosted by Lisa Walker and produced by Neuroendocrine Cancer UK, this podcast shines a light on neuroendocrine and other often-overlooked cancers, offering information, support, and connection to anyone affected.
The Invisible Cancer - Bringing Visibility to Neuroendocrine CancerÂ
Bridging Pharma and Patients in Neuroendocrine Cancer Care
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
🎙️ In this episode of the Not Just NE Cancer podcast, Neuroendocrine Cancer UK CEO and Co-Founder, Cathy Bouvier Ellis sits down with Tanya Hills, Global Patient Engagement Lead at Boehringer Ingelheim.
Together, they explore:
- Common misconceptions about the pharmaceutical industry
- How patient organisations and the industry can work collaboratively
- How effective these collaborations can be
Tanya also highlights a current clinical trial led by Boehringer Ingelheim for Extrapulmonary Neuroendocrine Carcinoma (EP-NEC). You can find more information about this trial here:
🔗 Boehringer Ingelheim – EP-NEC Clinical Trial
To learn more about ongoing neuroendocrine cancer research, visit our website:
🔗 Neuroendocrine Cancer UK – Research
